CN1245210C - Ready made traditional Chinese medicine for treating hyperplasia of mammary glans - Google Patents
Ready made traditional Chinese medicine for treating hyperplasia of mammary glans Download PDFInfo
- Publication number
- CN1245210C CN1245210C CNB2004100241095A CN200410024109A CN1245210C CN 1245210 C CN1245210 C CN 1245210C CN B2004100241095 A CNB2004100241095 A CN B2004100241095A CN 200410024109 A CN200410024109 A CN 200410024109A CN 1245210 C CN1245210 C CN 1245210C
- Authority
- CN
- China
- Prior art keywords
- hyperplasia
- mammary glands
- chinese patent
- patent medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a Chinese patent medicine for treating hyperplasia of mammary glands, which is prepared from the raw materials by the following parts by weight: 9 to 30 g of selfheal spike, 9 to 30g of herba lamin, 9 to 18g of herba epimedii, 9 to 30g of raw oyster shell, 9 to 18g of asparagus, 9 to 15g of zedoary, 6 to 15g of bupleurum root, 6 to 18g of pangolin, 9 to 15g of corydalis tuber and 9 to 15g of white atractylodes rhizome. The present invention has the functions of soothing the liver, invigorating the kidney, promoting qi circulation, relieving pain, promoting blood circulation, removing blood stasis, dispersing accumulation of pathogen, eliminating sputum and alleviating hyperplasia, and is used for mainly treating hyperplasia of mammary glands, which is caused by liver depression, renal deficiency, qi stagnation, blood stasis and sputum coagulation.
Description
Technical field
The present invention relates to medicine, is a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands
Background technology
Breast crack hypertrophy is that the women of child-bearing age's length is seen disease and frequently-occurring disease, accounts for the women of child-bearing age's 40%, and wherein, canceration rate is 8.6-14%, and Drug therapy generally adopts Western medicine or Chinese patent medicine, and the western medicine produce effects is fast, but side effect is big, and has recurrent.Because Chinese medicine has advantages such as treating both the principal and secondary aspects of a disease, be many patients' choice drug so adopt Chinese patent drugs for treatment.But existing Chinese medicine still exists deficiency: cure rate is low, is generally about 30%, and obvious effective rate is about 84-90% etc.
Summary of the invention
The objective of the invention is, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands is provided, it can make its cure rate reach about 43%, and it is about 96% that total effective rate reaches, and relapse rate is low, has no side effect.
The present invention provides following technical scheme in order to finish goal of the invention: it is made up of the raw material of following weight parts: Spica Prunellae 9-30g, Thallus Laminariae (Thallus Eckloniae) 9-30g, Herba Epimedii 9-18g, Concha Ostreae 9-30g, Radix Asparagi 9-18g, Rhizoma Curcumae 9-15g, Radix Bupleuri 6-15g, Squama Manis 6-18g, Rhizoma Corydalis 9-15g, Rhizoma Atractylodis Macrocephalae 9-15g.Described Squama Manis 6-18g can respectively 50% substituting with Bombyx Batryticatus and Myrrha raw material weight.Described Thallus Laminariae (Thallus Eckloniae) 9-30g, the 9-30g of available Sargassum raw material weight substitutes.The consumption of described Squama Manis is 6-12g.Become to form among the present invention: Spica Prunellae 15-22g, Thallus Laminariae (Thallus Eckloniae) 15-22g, Herba Epimedii 12-16g, Concha Ostreae 15-20g, Radix Asparagi 12-16g, Rhizoma Curcumae 11-13g, Radix Bupleuri 8-13g, Squama Manis 8-10g, Rhizoma Corydalis 10-13g, Rhizoma Atractylodis Macrocephalae 8-12g by the raw material of following weight parts.Medicament of the present invention is a capsule.
The function of medicine of the present invention: soothing the liver the kidney invigorating, promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, reducing phlegm disappears increases.Main treatment stagnation of liver-QI is suffered from a deficiency of the kidney, the hyperplasia of mammary glands of qi depression to blood stasis expectorant due to coagulating.The described raw material of medicine of the present invention, wherein Spica Prunellae and Thallus Laminariae (Thallus Eckloniae) are in order to soft perpendicular eliminating stagnation, and reducing phlegm disappears increases to monarch drug; Wear Squama Manis, Rhizoma Curcumae, Concha Ostreae blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, reducing phlegm disappears increases.Join the Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, the Herba Epimedii warming and recuperating the kidney-YANG, the Radix Asparagi nourishing kidney yin had both been strengthened hard masses softening and resolving, the power that reducing phlegm disappears increases, treating the liver is strongly fragrant again simultaneously suffers from a deficiency of the kidney morbidity originally, and these two groups it be ministerial drug; Rhizoma Atractylodis Macrocephalae spleen invigorating QI invigorating with living extremely mental disorder source, and can restrict hard masses softening and resolving, controls the medicine impairing the spleen and stomach of blood and dissolving stasis, the Rhizoma Corydalis promoting the circulation of QI to relieve pain, and blood circulation promoting and blood stasis dispelling is promoting flow of QI and blood analgesic good medicine, is adjuvant drug altogether; Radix Bupleuri remove to be transferred and to be reached mechanism of qi, outside the dispersing the stagnated live-QI to relieve the stagnation of QI, can guide the through Liver Channel disease of all medicines messenger drug of doing again.Raw material of the present invention wherein also has Res fungibiles, and the weight portion 9-15g of Pericarpium Citri Reticulatae Viride raw material can substitute Rhizoma Corydalis 9-15g, and the weight portion 9-15g of rhizoma sparganic raw material can substitute Rhizoma Curcumae 9-15g.Alternative materials of the present invention all can produce effects equivalent.
The present invention draws through clinical trial, its cure rate all is significantly improved than matched group (asparagine sheet, the peaceful granule of breast, RUHE SANJIE PIAN, PINGXIAO PIAN), be about 43.75%, total effective rate than matched group asparagine sheet 89%, peaceful particulate 90%, the RUHE SANJIE PIAN of breast 84.49%, 92.5% all being significantly increased of PINGXIAO PIAN, be about 98.57%, and relapse rate is low, is about 2.615%, has no side effect.
The specific embodiment
Manufacture method of the present invention all adopts the manufacture method of known Chinese patent medicine, and medicine of the present invention can adopt following arbitrary component to implement:
1, Spica Prunellae 12g, Thallus Laminariae (Thallus Eckloniae) 12g, Herba Epimedii 9g, Concha Ostreae 9g, Radix Asparagi 10g, Rhizoma Curcumae 9g, Radix Bupleuri 6g, Squama Manis 6g, Rhizoma Corydalis 9g, Rhizoma Atractylodis Macrocephalae 9g.
2, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
3, Spica Prunellae 25g, Thallus Laminariae (Thallus Eckloniae) 25g, Herba Epimedii 16g, Concha Ostreae 16g, Radix Asparagi 12g, Rhizoma Curcumae 12g, Radix Bupleuri 14g, Squama Manis 10g, Rhizoma Corydalis 13g, Rhizoma Atractylodis Macrocephalae 13g.
4, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Bombyx Batryticatus 9g, Myrrha 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
5, Spica Prunellae 18g, Sargassum 20g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
6, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Atractylodis Macrocephalae 9g.
7, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, rhizoma sparganic 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
8, Spica Prunellae 18g, Sargassum 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, rhizoma sparganic 12g, Radix Bupleuri 12g, Bombyx Batryticatus 9g, Myrrha 9g, Pericarpium Citri Reticulatae Viride 12g, Rhizoma Atractylodis Macrocephalae 9g.
Claims (6)
1, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands, it is characterized in that: it is made up of the raw material of following weight parts: Spica Prunellae 9-30g, Thallus Laminariae (Thallus Eckloniae) 9-30g, Herba Epimedii 9-18g, Concha Ostreae 9-30g, Radix Asparagi 9-18g, Rhizoma Curcumae 9-15g, Radix Bupleuri 6-15g, Squama Manis 6-18g, Rhizoma Corydalis 9-15g, Rhizoma Atractylodis Macrocephalae 9-15g.
2, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands according to claim 1 is characterized in that: described Squama Manis 6-18g can respectively 50% substituting with Bombyx Batryticatus and Myrrha raw material weight.
3, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands according to claim 1 is characterized in that: described Thallus Laminariae (Thallus Eckloniae) 9-30g, the 9-30g of available Sargassum raw material weight substitutes.
4, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands according to claim 1, it is characterized in that: the consumption of described Squama Manis is 6-12g.
5, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands according to claim 1, it is characterized in that: it is made up of the raw material of following weight parts: Spica Prunellae 15-22g, Thallus Laminariae (Thallus Eckloniae) 15-22g, Herba Epimedii 12-16g, Concha Ostreae 15-20g, Radix Asparagi 12-16g, Rhizoma Curcumae 11-13g, Radix Bupleuri 8-13g, Squama Manis 8-10g, Rhizoma Corydalis 10-13g, Rhizoma Atractylodis Macrocephalae 8-12g.
6, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands according to claim 5, it is characterized in that: described medicament is a capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100241095A CN1245210C (en) | 2004-05-18 | 2004-05-18 | Ready made traditional Chinese medicine for treating hyperplasia of mammary glans |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100241095A CN1245210C (en) | 2004-05-18 | 2004-05-18 | Ready made traditional Chinese medicine for treating hyperplasia of mammary glans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1579511A CN1579511A (en) | 2005-02-16 |
| CN1245210C true CN1245210C (en) | 2006-03-15 |
Family
ID=34581965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100241095A Expired - Fee Related CN1245210C (en) | 2004-05-18 | 2004-05-18 | Ready made traditional Chinese medicine for treating hyperplasia of mammary glans |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1245210C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191373B (en) * | 2013-03-30 | 2014-04-02 | 侯萍 | Traditional Chinese medicine for treating kidney deficiency type breast hyperplasia and preparation method of traditional Chinese medicine |
| CN104491544A (en) * | 2014-12-25 | 2015-04-08 | 刘新霞 | Traditional Chinese medicinal composition for treating breast hyperplasia caused by phlegm stagnation and sluggish |
| CN107019780A (en) * | 2017-02-04 | 2017-08-08 | 洛阳士雄聚元医疗集团股份有限公司 | A kind of Chinese medicine composition for treating the proliferation of mammary gland |
-
2004
- 2004-05-18 CN CNB2004100241095A patent/CN1245210C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1579511A (en) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1446558A (en) | Blaster for treating rheumatoid arthritis | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN1245210C (en) | Ready made traditional Chinese medicine for treating hyperplasia of mammary glans | |
| CN1883552A (en) | A Chinese medicine for treating mastopathy and method for preparing same | |
| CN101130053A (en) | Traditional Chinese medicine for treating exogenous injury type blood stasis headache | |
| CN1939523A (en) | Chinese-medicinal preparation for treating hysteromyoma and its making method | |
| CN1233354C (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN102872313A (en) | Traditional Chinese medicine qi-tonifying and kidney-nourishing decoction for treating henoch-schonlein purpura nephritis | |
| CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
| CN104873692A (en) | Traditional Chinese medicine preparation for treating esophagus cancer | |
| CN1872136A (en) | Medication for treating neonatal jaundice, and method of use. | |
| CN1058892C (en) | Drug for curing lung cancer | |
| CN1092971C (en) | Chinese medicine for treating rheumatism | |
| CN107753700A (en) | A kind of medicine for treating chronic hepatitis | |
| CN1061249C (en) | Quick-acting traditional Chinese medicine for curing hepatitis B | |
| Zhuang et al. | Thoughts on the treatment of cancer pain under the guidance of traditional Chinese medicine | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN1278730C (en) | Medicine for curing necrosis of femoral head | |
| CN102139062A (en) | Novel traditional Chinese medicine for treating pharyngitis and tonsillitis | |
| CN1070709C (en) | Chinese drug preparation for curing hepatopathy and its preparation | |
| CN1181839C (en) | Tumor treating antiphlogistic medicine liquid | |
| CN1163136A (en) | Medicine for curing stone in urinary system | |
| CN101091785A (en) | Composition of Chinese traditional medicine for treating hyperplasia of mammary glands, and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060315 Termination date: 20140518 |